Recent Post

hero image

NPC backs Chinova Bioworks, ALT-PRO Advantage

  • Mar 06, 2025
hero image

SimplyCast, Pico Public Cloud Sign MOU

  • Mar 06, 2025
hero image

Aeon Blue Eyes $10M Seed Round

  • Mar 05, 2025

recent news

Arolytics Eyes U.S. Expansion

  • Nov 13, 2023
  • Avery Mullen

When Arolytics raised $3.5 million last month it did so on the back of 250 percent revenue growth from 2021 to 2022, as governments in Canada and the United States tee up stricter methane emissions rules governing oil and gas projects.

Liz

read more

Climatetech Heating Up: Tom Rand

  • Nov 13, 2023
  • Avery Mullen

Atlantic Canadian cleantech companies like Dartmouth-based superstar CarbonCure and Halifax’s Arolytics, which recently raised $3.5 million, stand to benefit from a broad shift in attitudes towards environmental technology plays from investors not

read more

Genesis Anounces Pitch & Pick Finalists

  • Nov 09, 2023
  • Avery Mullen

Newfoundland and Labrador innovation hub Genesis has announced the six companies it has selected to compete in a revised version of its Pitch & Pick startup competition Nov. 15, this time with $15,000 of prizes on offer.

The winner of the Pitch &

read more

Life Sciences NS Offers Mentorship Program for 12 Execs

  • Nov 09, 2023
  • Avery Mullen

Industry group Life Sciences Nova Scotia is looking for applicants to the 2024 cohort of its CEO Circle mentorship program, though space is capped at 12 entrepreneurs.

The program is designed to facilitate peer-to-peer mentoring between executives

read more

Greenlight Launching HarvestIQ

  • Nov 08, 2023
  • Avery Mullen

Greenlight Analytical, the Halifax maker of testing equipment for cannabis crops, is launching its first product, the HarvestIQ, on the back of raising about $300,000 over the summer.

The HarvestIQ is a modified mass spectrometer – a machine that

read more

Site 20/20 Ranks Sixth in Deloitte Fast 50

  • Nov 08, 2023
  • Avery Mullen

Halifax-based Site 20/20 has cracked Deloitte’s prestigious Technology Fast 50 list of Canada’s quickest-growing startups on the back of remarkable 2,392 percent revenue growth from 2019 to 2023.

Led by CEO Mitch Hollohan, Site 20/20’s flagship

read more

Myomar Nears Commercialization, Almost $1M Raised

  • Nov 08, 2023
  • Avery Mullen

Halifax medical testing startup Myomar Molecular is conducting the first beta tests of its product as it nears the close of a $1 million funding round, with $900,000 committed.

Founder Rafaela Andrade said in an interview the testing began in

read more

Dal Innovates Seeks Discover Applicants

  • Nov 08, 2023
  • Avery Mullen

Dalhousie University is looking for applicants to its Lab2Market Discover program, the precursor program to the school’s Lab2Market Validate accelerator, with two format options: a three-day intensive program and a less condensed, 10-week version.

read more

SiftMed Secures Clients, Wins techNL Award

  • Nov 06, 2023
  • Avery Mullen

SiftMed, the St. John’s maker of software that helps law offices and insurance companies organize and search jumbled medical records, has been named Startup of the Year by techNL in the wake of securing its first paying clients.

SiftMed earlier

read more

Halifax Partnership Seeks Circular Economy Food Businesses

  • Nov 06, 2023
  • Avery Mullen

The Halifax Innovation Outpost, an initiative of the Halifax Partnership, is offering up to $5,000 for startups to pilot or test circular economy technologies for the food industry, but applications are due by Nov. 13.

The Circular Food Solution

read more

KardioDiagnostix Eyes Launch in 18 Months

  • Nov 06, 2023
  • Peter Moreira

A new Halifax-based startup is aiming to improve the process of assessing heart murmurs in children, and is hoping to have its Software-as-a-Service product in the market in 2025.

KardioDiagnostix, one of the companies named to Invest Nova Scotia’s

read more

AffinityImmuno Reveals Strong Preclinical Results

  • Nov 05, 2023
  • Avery Mullen

Charlottetown-based life sciences company AffinityImmuno has met with good results in preclinical trials for an antiviral compound that shows promise against COVID-19, with infected mice seeing as much as an 81 percent reduction in the amount of

read more